BEGIN:VCALENDAR
VERSION:2.0
PRODID:Spatie calendar-links
BEGIN:VEVENT
UID:d01260f66f1d9aaa0b8081813ac08778
SUMMARY:Short Communication Session 1.2\n\n
DTSTAMP:20240912T140000Z
DTSTART:20240912T140000Z
DTEND:20240912T150000Z
DESCRIPTION:Short Communication Session 1.2\n\n\n\nChair(s): C. Ribi\, Lausanne (CH)\; A. K. Pröbstel\, Basel (CH)\n\nPresentations:\n\nEfficacy and Safety of mRNA-1345\, an RSV Vaccine\, in Older Adults: Results Through ≥6 Months of Follow-Up\nReferent(s): D. L. Presotto\, Basel (CH)\; J. Goswami\, Cambridge\, MA (US)\; E. Wilson\, Cambridge\, MA (US)\; P. A. Doreski\, Buenos Aires (AR)\; G. Perez Marc\, Buenos Aires (AR)\; G. Jimenez\, Miami\, FL (US)\; F. Priddy\, Cambridge\, MA (US)\; N. Lin\, Cambridge\, MA (US)\; N. Le Cam\, Cambridge\, MA (US)\; K. Slobod\, Cambridge\, MA (US)\; S. K. Stoszek\, Cambridge\, MA (US)\; C. A. Panozzo\, Cambridge\, MA (US)\; A. Kapoor\, Cambridge\, MA (US)\; L. Wilson\, Cambridge\, MA (US)\; J. Du\, Cambridge\, MA (US)\; L. Lan\, Cambridge\, MA (US)\; C. Reuter\, Cambridge\, MA (US)\; H. Zhou\, Cambridge\, MA (US)\; J. M. Miller\, Cambridge\, MA (US)\; R. Das\, Cambridge\, MA (US)\n\nTackling the HIV Reservoir with HIV-resistant Anti-PD-1 CAR-T Cells\nReferent(s): L. Ermellino\, Lausanne (CH)\; N. Kadzioch\, Zurich (CH)\; S. Georgakis\, Lausanne (CH)\; R. Banga\, Lausanne (CH)\; A. Alcaraz-Serna\, Lausanne (CH)\; O. Alfageme-Abelló\, Lausanne (CH)\; R. Porret\, Lausanne (CH)\; E. Lana\, Lausanne (CH)\; M. Perreau\, Lausanne (CH)\; C. Fenwick\, Lausanne (CH)\; C. Petrovas\, Lausanne (CH)\; R. Speck\, Zurich (CH)\; G. Pantaleo\, Lausanne (CH)\; Y. Muller\, Lausanne (CH)\n\nComplete Remission in Eosinophilic Granulomatosis with Polyangiitis (EGPA) in the MANDARA Trial of Benralizumab vs Mepolizumab\nReferent(s): P. Wörner\, Baar (CH)\; M. E. Wechsler\, Denver (US)\; N. Agmon-Levin\, Ramat Gan (IL)\; D. R. W. Jayne\, Cambridge (GB)\; P. A. Merkel\, \, Philadelphia (US)\; C. Pagnoux\, Toronto (CA)\; U. Specks\, Rochester (US)\; L. Börjesson Sjö\, Gothenburg (SE)\; S. Necander\, Gothenburg (SE)\; A. Shavit\, Cambridge (GB)\; C. Walton\, Cambridge (GB)\n\nEffective intralymphatic immunotherapy (ILIT) of allergic rhinoconjunctivitis with grass allergoid microcrystalline tyrosine adsorbate: a DBRCT\nReferent(s): P. Johansen\, Zurich (CH)\; L. Šošić\, Zurich (CH)\; T. M. Kündig\, Zurich (CH)\; H. J. Hoffmann\, Aarhus (DK)\; E. C. Widmer\, Zurich (CH)\; S. Flory\, Zurich (CH)\; M. Paolucci\, Zurich (CH)\; A. Duda\, Zurich (CH)\; A. Chabot\, Zurich (CH)\; C. Lang\, Zürich (CH)\; P. Schmid-Grendelmeier\, Zurich (CH)\; T. Andermatt\, Zurich (CH)\; S. Bösch\, Zurich (CH)\; M. F. Kramer\, Munich (DE)\n\nEffect of Benralizumab vs Mepolizumab on Reduction in Oral Glucocorticoid (OGC) Use in Eosinophilic Granulomatosis with Polyangiitis (EGPA)\nReferent(s): A. Rahmany\, Baar (CH)\; B. Hellmich\, Kirchheim unter Teck (DE)\; M. E. Wechsler\, Denver (US)\; P. A. Merkel\, \, Philadelphia (US)\; P. Nair\, Hamilton (CA)\; A. Bourdin\, Montpellier (FR)\; D. R. W. Jayne\, Cambridge (GB)\; F. Roufosse\, Brussels (BE)\; L. Börjesson Sjö\, Gothenburg (SE)\; Y. Fan\, Gaithersburg (US)\; A. Menzies-Gow\, Cambridge (GB)\; S. Necander\, Gothenburg (SE)\; A. Shavit\, Cambridge (GB)\n\nInvestigating mitochondrial metabolism dysfunction in SLE&nbsp\;NK&nbsp\;cells and exploring therapeutic approaches with Hydroxychloroquine and Urolithin-A\nReferent(s): N. Fluder\, Lausanne (CH)\; M. Humbel\, Lausanne (CH)\; C. Ribi\, Lausanne (CH)\; D. Comte\, Lausanne (CH)\n\n
LOCATION:Room F
END:VEVENT
END:VCALENDAR